http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3546911-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21c08c0f5b7157094b9165e9c2ec46f1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate | 1985-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2edcf6ebd8f76d3adf8a98eb11ba7238 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f755e6d07093af341a3b5e0ae3b674 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971b20e6fa2189da02c3ac78d85e06c4 |
| publicationDate | 1997-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-3546911-C2 |
| titleOfInvention | Parenteral nutrition product containing crystalline maltose and use |
| abstract | (1). New crystalline alpha-maltose, (A), contains at least 55 wt.% w.r.t. dry solids, of alpha-maltose isomer and has a residual content of beta-maltose isomer. (A) has a main diffraction angles (2 theta) 12.6, 20.3 and 21.9 deg., in the X-ray diffraction analysis with CuK alpha-rays. (2). In the prepn. of (A), (a) a highly conc. syrup contg. less than 10 (2-9) wt.% moisture is prepd. from highly pure maltose contg. at least 85 wt.% maltose, w.r.t. dry solids. (b) The alpha-maltose is crystallised from the syrup at 50-130 deg.C in the presence of crystal nuclei and (c) the (A) formed is recovered. (3) The use of a cation exchanger resin in a fractionation step is claimed. (A) are also useful in the mfr. of ready-to-use prods. for parenteral feeding, e.g. by injection, incubation or haemodialysis. These prods. contain at least one additional foodstuff, e.g. a saccharide, protein, aminoacid, oil, fat, vitamin and/or minerals and are present in finely-distributed form. (A) May be used in cosmetic compsns., tobacco and pharmaceuticals and in animal feedstuffs. The alpha-maltose is obtd. in finely-divided form, has degree of colouring below 1 and can be introduced into foodstuffs without dissolving. (A) Have a high affinity to oils and fats, a mild sweetness and resist storage in a closed container. Pref. crystallisation takes place under high pressure, with dehydration and may be followed by an ageing step. |
| priorityDate | 1984-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.